If you rely on the lifesaving drug epinephrine for severe allergic reactions, the controversy over high-priced auto-injectors probably shouldn't be your only worry. A recently released report by the ...

Anaphylaxis is a serious, potentially life-threatening allergic reaction that can affect several organ systems in the body and may threaten breathing and blood circulation. The most common causes of ...

Individuals at risk of anaphylaxis—an acute systemic hypersensitivity reaction to an allergen or trigger, typically associated with skin reactions, nausea/vomiting, difficulty breathing, and shock—are ...

Please provide your email address to receive an email when new articles are posted on . Epinephrine autoinjectors may have little effect on surviving anaphylaxis events. Research is needed in ...

Pharmaceutical company Kaleo said Wednesday that it will reintroduce its compact epinephrine autoinjector to the US market in the first half of 2017. Auvi-Q can be used to treat life-threatening ...

ALK presents new findings that directly compare user preference between needle-free nasal and injectable adrenaline treatments for anaphylaxis, demonstrating that 88% of participants prefer ...

Auvi-Q 0.1mg is the first epinephrine auto-injector specifically designed for the treatment of life-threatening allergic reactions, including anaphylaxis, in infants and small children weighing 16.5 ...

Please provide your email address to receive an email when new articles are posted on . The costs of epinephrine autoinjectors have decreased since generic options arrived in 2016, but these costs ...

Proposals would require schools to stock adrenaline injectors, train staff and implement allergy policies, strengthening ...

The plans, due to come into force in September, follow support for Benedict's Law, a campaign to improve allergy safety in schools.

When you shop through retailer links on our site, we may earn affiliate commissions. 100% of the fees we collect are used to support our nonprofit mission. Learn more. If you rely on the lifesaving ...

ALK’s new data reveals 9 in 10 people prefer EURneffy, a needle-free nasal adrenaline spray, over auto-injectors: Denmark Monday, March 2, 2026, 18:00 Hrs [IST] ALK, a global sp ...